Imaging Rates Scrutinized; Conclusions Mixed
They also suggest that the increase is due to the lack of evidence-based guidance on when the studies help prolong life or make determinations further treatment or hospice. To date, routine use of imaging is recommended only in stage IV patients with colorectal cancer that has spread to the liver or lung to determine suitability for resection.
"Such discretionary decision-making, ie, the 'gray' area where recommendations are equivocal or nonexistent, is known to drive higher healthcare spending," the researchers wrote.
Additionally, the researchers discovered tremendous variability throughout the country, with patients in the top 10% receiving at least one scan per month during continuing care, and at least three in their last month of life.
"Imaging, although it often leads to (appropriate) palliative measures, may also distract patients from focusing on achievable end-of-life goals, require them to spend more of their limited time in medical care settings, and/or provoke anxiety."
- Ebola: Health Officials Try to Quell Front Line Fears
- Reducing Readmissions Starts with Better Collaboration
- Ebola: A New Normal in Dallas
- Partners HealthCare M&A Deal Under Scrutiny
- Readmissions: No Quick Fix to Costly Hospital Challenge
- How Educated Nurses Save Money
- 'Overtreatment' Debate Circles Back to Lung Cancer Screening
- As virus spreads, insurers exclude Ebola from new policies
- Defensive Medicine Still Prevalent Despite Tort Reform
- How Top-Ranked MA Plans Earn Their Stars